HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 49 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,538,672 | -67.9% | 1,758,000 | -67.9% | 0.00% | -60.0% |
| Q1 2023 | $4,786,688 | +8.9% | 5,469,000 | +21.0% | 0.01% | 0.0% |
| Q4 2022 | $4,395,632 | -10.3% | 4,519,000 | -20.2% | 0.01% | 0.0% |
| Q3 2022 | $4,899,000 | +475.0% | 5,663,000 | +499.9% | 0.01% | +400.0% |
| Q2 2022 | $852,000 | – | 944,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 89,152 | $76,268,000 | 5.41% |
| CAMDEN ASSET MANAGEMENT L P /CA | 64,461,000 | $54,550,000 | 1.83% |
| Penn Mutual Asset Management | 1,305,000 | $1,105,000 | 1.45% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 79,311,000 | $67,117,000 | 1.23% |
| ZAZOVE ASSOCIATES LLC | 9,978,000 | $8,481,000 | 0.77% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,500,000 | $25,112,000 | 0.46% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,279,000 | $7,014,000 | 0.39% |
| SSI INVESTMENT MANAGEMENT LLC | 5,833,000 | $4,936,000 | 0.33% |
| Lombard Odier Asset Management (Europe) Ltd | 6,266,000 | $5,334,000 | 0.28% |
| MACKAY SHIELDS LLC | 7,716,000 | $6,568,000 | 0.17% |